Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
These medications are designed to be effective when injected into any of the approved subcutaneous sites, with product information confirming no clinically relevant differences in medication exposure between the recommended injection areas
Subcut, Subcutaneous injection
You may notice increased body heat and slightly elevated resting heart rate, both signs of the thermogenic effect
January 2022: Novo Nordisk announced the launch of oral semaglutide in India for the treatment of type 2 diabetes
Monitoring and follow-up should continue as recommended for tirzepatide therapy, typically including assessment of glycemic control (A1C), weight, gastrointestinal tolerability, and screening for potential adverse effects
Semaglutide also reduces the risk of cardiovascular events and improves cardiometabolic risk factors and functional outcomes
US$ 22.75
US$ 29.47
US$ 28.86
US$ 26.30
